Tag: biosimilars vs generics
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Medications
Archives
Recent-posts
Vasculitis: Understanding Autoimmune Inflammation of Blood Vessels
Jan, 18 2026
Is saferdrugsnow.com a Legit Online Pharmacy? Honest Review, Facts, and Tips
Jul, 7 2025
Combination Cholesterol Therapy with Reduced Statin Doses: A Smarter Approach
Jul, 27 2026
How to Prepare for Pediatric Procedures with Pre-Op Medications: A Step-by-Step Guide
Dec, 25 2025
Leukeran Explained: Dosage, Uses, Side Effects & FAQs
Sep, 21 2025